Analysts expect Myriad Genetics Inc to report revenue of 200.49 M for Q3 26, against a range of 184.92 M to 216.06 M. The most recent reported quarter, Q2 26, came in at 190.70 M, a 12.6% miss against the 218.19 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 213.30 M | 210.60 M | 195.90 M | 213.10 M | 205.70 M | 209.80 M | 200.40 M | 190.70 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 222.37 M | 233.63 M | 205.35 M | 221.43 M | 211.16 M | 217.67 M | 227.02 M | 224.82 M | 216.06 M | 220.09 M | 211.89 M | 224.02 M | 197.67 M | 231.70 M | 239.07 M | 218.09 M | ||||||||||
| Low Estimate | 185.38 M | 205.99 M | 183.34 M | 191.39 M | 180.84 M | 185.45 M | 198.27 M | 211.56 M | 184.92 M | 184.21 M | 174.03 M | 200.09 M | 184.25 M | 190.43 M | 219.82 M | 199.04 M | ||||||||||
| Consensus Estimate | 203.88 M | 219.81 M | 194.35 M | 206.41 M | 196.00 M | 201.56 M | 212.64 M | 218.19 M | 200.49 M | 202.15 M | 192.96 M | 212.06 M | 190.96 M | 211.07 M | 229.44 M | 208.56 M |
Analysts expect Myriad Genetics Inc to report earnings per share of -0.22 for Q3 26, against a range of -0.24 to -0.20. The most recent reported quarter, Q2 26, came in at -0.25, a 316.7% miss against the -0.06 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.06 | 0.03 | -0.03 | 0.05 | 0.00 | 0.04 | -0.09 | -0.25 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.02 | 0.03 | -0.05 | -0.01 | -0.01 | -0.01 | -0.06 | -0.06 | -0.20 | -0.19 | -0.13 | -0.15 | -0.17 | -0.17 | -0.11 | -0.09 | ||||||||||
| Low Estimate | 0.02 | 0.03 | -0.05 | -0.01 | -0.01 | -0.01 | -0.08 | -0.06 | -0.24 | -0.21 | -0.15 | -0.17 | -0.21 | -0.21 | -0.11 | -0.09 | ||||||||||
| Consensus Estimate | 0.02 | 0.03 | -0.05 | -0.01 | -0.01 | -0.01 | -0.07 | -0.06 | -0.22 | -0.20 | -0.14 | -0.16 | -0.19 | -0.19 | -0.11 | -0.09 |
Pull Wall Street consensus for Myriad Genetics Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MYGN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MYGN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MYGN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();